» Articles » PMID: 20066732

Tube Feeding, the Microbiota, and Clostridium Difficile Infection

Overview
Specialty Gastroenterology
Date 2010 Jan 13
PMID 20066732
Citations 33
Authors
Affiliations
Soon will be listed here.
Abstract

Clostridium difficile (C. difficile) is now the leading cause of nosocomial diarrhea in the USA, accounting for 30% of patients with antibiotic-associated diarrhea, 70% of those with antibiotic-associated colitis, and most cases of pseudomembranous colitis. The organism has evolved over the last 8 years to become more virulent and resistant to antimicrobials (NAP1/027 strain) causing a more severe form of the disease that has increased mortality and healthcare costs. While it is generally accepted that the problem results from the overuse of antibiotics, and in particular second and third generation cephalosporins, fluoroquinolones and macrolides, recent studies suggest that acid suppression with proton pump inhibitors (PPIs) may be equally culpable. A further common, but less recognized, etiological factor is the prolonged use of elemental diets. Such diets are totally absorbed within the small intestine and therefore deprive the colonic microbiota of their source of nutrition, namely dietary fiber, fructose oligosaccharides, and resistant starch. The resultant suppression of colonic fermentation leads to suppression of the "good" bacteria, such as butyrate-producers (butyrate being essential for colonic mucosal health), and bifidobacteria and the creation of a "permissive" environment for C. difficile colonization and subsequent infection. Based on this analysis, the best chance of suppressing the emerging C. difficile epidemic is to adopt a 3-pronged attack consisting of (1) avoidance of the use of prophylactic antibiotics, (2) the avoidance of prophylactic PPIs, and (3) the conversion of elemental diet feeding to a diet containing adequate indigestible carbohydrate after the first week of critical illness. In this review, we highlight the rising worldwide incidence of C. difficile associated diarrhea and the role played by non-residue diets in destabilizing the colonic microbiota.

Citing Articles

Risk factors of carbapenemase-producing Enterobacterales acquisition among adult intensive care unit patients at a Kentucky Academic Medical Center.

Wilson J, Sanderson W, Westgate P, Winter K, Forster D Infect Prev Pract. 2023; 5(4):100310.

PMID: 37767313 PMC: 10520311. DOI: 10.1016/j.infpip.2023.100310.


Infections among Pediatric Patients Hospitalized at an Oncology Department of a Tertiary Hospital in Poland.

Lemiech-Mirowska E, Gaszynska E, Sierocka A, Kiersnowska Z, Marczak M Medicina (Kaunas). 2023; 59(8).

PMID: 37629653 PMC: 10456884. DOI: 10.3390/medicina59081363.


Aetiology of hospital-acquired diarrhoea in under-five children from an urban hospital in East Delhi, India.

Singh N, Shah D, Singh T, Saha R, Das S, Datt S Indian J Med Res. 2023; 156(4&5):624-631.

PMID: 36926779 PMC: 10231740. DOI: 10.4103/ijmr.IJMR_4138_20.


Concurrent and Subsequent Co-Infections of Colitis in the Era of Gut Microbiota and Expanding Treatment Options.

Trunfio M, Scabini S, Rugge W, Bonora S, Di Perri G, Calcagno A Microorganisms. 2022; 10(7).

PMID: 35888994 PMC: 9317215. DOI: 10.3390/microorganisms10071275.


Risk Factors of Patients With Diarrhea for Having Infection.

Lang V, Gunka K, Ortlepp J, Zimmermann O, Gross U Front Microbiol. 2022; 13:840846.

PMID: 35359708 PMC: 8963458. DOI: 10.3389/fmicb.2022.840846.


References
1.
Bartlett J . Clinical practice. Antibiotic-associated diarrhea. N Engl J Med. 2002; 346(5):334-9. DOI: 10.1056/NEJMcp011603. View

2.
Cunningham R, Dial S . Is over-use of proton pump inhibitors fuelling the current epidemic of Clostridium difficile-associated diarrhoea?. J Hosp Infect. 2008; 70(1):1-6. DOI: 10.1016/j.jhin.2008.04.023. View

3.
OKeefe S . A guide to enteral access procedures and enteral nutrition. Nat Rev Gastroenterol Hepatol. 2009; 6(4):207-15. DOI: 10.1038/nrgastro.2009.20. View

4.
Loo V, Poirier L, Miller M, Oughton M, Libman M, Michaud S . A predominantly clonal multi-institutional outbreak of Clostridium difficile-associated diarrhea with high morbidity and mortality. N Engl J Med. 2005; 353(23):2442-9. DOI: 10.1056/NEJMoa051639. View

5.
Lewis S, Franco S, Young G, OKeefe S . Altered bowel function and duodenal bacterial overgrowth in patients treated with omeprazole. Aliment Pharmacol Ther. 1996; 10(4):557-61. DOI: 10.1046/j.1365-2036.1996.d01-506.x. View